Andreas Woppmann

Andreas Woppmann

Keine laufenden Positionen mehr

Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Andreas Woppmann

EinheitArt der EinheitIndustrie
9
Extinct Pharmaceuticals: Major 9
Public Company Biotechnology 5

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Andreas Woppmann

UnternehmenSektorVerknüpfte PersonenHauptposition
ABIOMED, INC. Medical Specialties

Charles Haaser

Director of Finance/CFO

TENAX THERAPEUTICS, INC. Pharmaceuticals: Major

Robyn Hunter

Director/Board Member

AMARIN CORPORATION PLC Pharmaceuticals: Major

James Gale

Director/Board Member

Miscellaneous Commercial Services

James Gale

Director/Board Member

DELCATH SYSTEMS, INC. Medical Specialties

Jonathan Lewis

Director/Board Member

LEE'S PHARMACEUTICAL HOLDINGS LIMITED Pharmaceuticals: Major

James Gale

Director/Board Member

Pharmaceuticals: Major

James Gale

Director/Board Member

FORTRESS BIOTECH, INC. Pharmaceuticals: Major

Robyn Hunter

Director of Finance/CFO

KNIGHT THERAPEUTICS INC. Pharmaceuticals: Major

James Gale

Director/Board Member

Pharmaceuticals: Major

James Gale

Chairman

Investment Banks/Brokers

Wei Wu

Corporate Officer/Principal

Miscellaneous Commercial Services

Jonathan Lewis

Corporate Officer/Principal

Adelphi University College/University

Wei Wu

Undergraduate Degree

The University of Chicago College/University

James Gale

Masters Business Admin

Yale University College/University

Jonathan Lewis

Doctorate Degree

Union College (New York) College/University

Robyn Hunter

Undergraduate Degree

New York University College/University

Wei Wu

Masters Business Admin

University of Arizona College/University

James Gale

Undergraduate Degree

Hospital/Nursing Management

Jonathan Lewis

Corporate Officer/Principal

Engineering & Construction

Wei Wu

Corporate Officer/Principal

ALAUNOS THERAPEUTICS, INC. Biotechnology

Robert P. Gale

Jonathan Lewis

Chief Tech/Sci/R&D Officer

Chief Executive Officer

University of the Witwatersrand College/University

Jonathan Lewis

Doctorate Degree

Medical Distributors

James Gale

Director/Board Member

Miscellaneous Commercial Services

James Gale

Director/Board Member

Pharmaceuticals: Major

James Gale

Director/Board Member

Miscellaneous Commercial Services

James Gale

Director/Board Member

Miscellaneous Commercial Services

Jonathan Lewis

Chairman

Pharmaceuticals: Major

James Gale

Director/Board Member

Pharmaceuticals: Major

James Gale

Director/Board Member

CHECKPOINT THERAPEUTICS, INC. Pharmaceuticals: Major

Robyn Hunter

Corporate Secretary

AVENUE THERAPEUTICS, INC. Pharmaceuticals: Major

Robyn Hunter

Corporate Secretary

MUSTANG BIO, INC. Pharmaceuticals: Major

Robyn Hunter

Corporate Secretary

TCR2 THERAPEUTICS INC. Pharmaceuticals: Major

Axel Hoos

Director/Board Member

Schochet Associates, Inc.

Robyn Hunter

Director of Finance/CFO

Pharmaceuticals: Major

James Gale

Director/Board Member

HYLORIS PHARMACEUTICALS SA Pharmaceuticals: Major

James Gale

Director/Board Member

Pharmaceuticals: Generic

James Gale

Director/Board Member

Pharmaceuticals: Major

Axel Hoos

Chief Executive Officer

Pharmaceuticals: Major

James Gale

Director/Board Member

Miscellaneous Commercial Services

Axel Hoos

Director/Board Member

Miscellaneous Commercial Services

James Gale

Director/Board Member

Pharmaceuticals: Major

James Gale

Director/Board Member

Police Organization Providing Peer Assistance, Inc.

Jonathan Lewis

Director/Board Member

Statistik

International

Vereinigte Staaten 39
Kanada 4
Hong Kong 3
Irland 2
Südafrika 2

Sektoral

Health Technology 26
Commercial Services 9
Consumer Services 8
Finance 4
Distribution Services 3

Operativ

Director/Board Member 64
Corporate Officer/Principal 26
Chairman 14
President 11
Director of Finance/CFO 10
  1. Börse
  2. Insiders
  3. Andreas Woppmann
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT